The impact of CYP2D6-predicted phenotype on tamoxifen treatment outcome in patients with metastatic breast cancer: Lammers LA, Mathijssen RHJ, van Gelder T, et al (Univ Hosp, Rotterdam, The Netherlands) Br J Cancer 103:765-771, 2010§